drugset
drugset / Trial / NCT03381144

A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Single and Multiple Ascending Doses of GDC-0334 and the Effect of Food on the Pharmacokinetics of GDC-0334 in Healthy Adult Participants

NCT03381144 ↗

Phase 1 Terminated 66 enrolled Genentech, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled, single-center, three-part study designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamic effects of single and multiple ascending doses of GDC-0334 and the effect of food on the pharmacokinetics of GDC-0334 in healthy adult participants.

Timeline

Start
2017-12-08
Primary completion
2019-04-29
Completion
2019-04-29

Outcome

Outcome not reported

Stopped: “Molecule development was terminated”

Drugs

EvaluationDrugModalityDoseRoute
Subject GDC-0334 Unknown — Oral

Indications

No indication recorded.